A new mechanism of leukemia drug resistance?

New England Journal of Medicine

Volumn 357, Issue 1, 2007, Pages 77-78

  Williams, David A ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARAGINASE; ASPARTATE AMMONIA LIGASE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; BONE MARROW; CELL ADHESION; CELL INTERACTION; CELL SURVIVAL; CLINICAL STUDY; HEMATOPOIETIC STEM CELL; HUMAN; LEUKEMIA; MESENCHYME CELL; MICROENVIRONMENT; PRIORITY JOURNAL; TREATMENT FAILURE;

EID: 34347385620     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMcibr072412     Document Type: Article

References (5)

1. Dexter TM, Allen TD, Lajtha LG. Conditions controlling the proliferation of haemopoietic stem cells in vitro. J Cell Physiol 1977;91:335-44.
2. Schofield R. The stem cell system. Biomed Pharmacother 1983;37:375-80.
3. Iwamoto S, Mihara K, Downing JR, Pui C-H, Campana D. Mesenchymal cells regulate the response of acute lymphoblastic leukemia cells to asparaginase. J Clin Invest 2007;117:1049-57.
4. Williams DA, Cancelas JA. Niche retreats for stem cells. Nature 2006;444:827-8.
5. Silverman LB, Gelber RD, Dalton VK, et al. Improved outcome for children with acute lymphoblastic leukemia: results of Dana-Farber Consortium Protocol 91-01. Blood 2001;97:1211-8.